Arnnon Geshuri - Feb 3, 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF PEOPLE OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Feb 3, 2023
Transactions value $
-$43,628
Form type
4
Date filed
2/7/2023, 03:11 PM
Previous filing
Feb 3, 2023
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise $2.05K +750 +1.01% $2.73* 75.1K Feb 3, 2023 Direct F1
transaction TDOC Common Stock Sale -$23.7K -750 -1% $31.63 74.3K Feb 3, 2023 Direct F1
transaction TDOC Common Stock Options Exercise $2.05K +750 +1.01% $2.73* 75.1K Feb 3, 2023 Direct F1
transaction TDOC Common Stock Sale -$24K -750 -1% $32.00 74.3K Feb 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Employee Stock Option (right to buy) Options Exercise $0 -750 -0.32% $0.00 232K Feb 3, 2023 Common Stock 750 $2.73 Direct F1, F2
transaction TDOC Employee Stock Option (right to buy) Options Exercise $0 -750 -0.32% $0.00 232K Feb 3, 2023 Common Stock 750 $2.73 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022.
F2 One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter.